Cita APA (7a ed.)
Hulskotte, L. M. G., de Jong, L. A. W., Huitema, A. D. R., Sijm, J., Desar, I., Smits, M., & van Erp, N. P. (2025). Substitution of ifosfamide for cyclophosphamide in the TI-CE regimen: Pharmacology and dose justification in a patient with refractory metastatic germ-cell tumor post-nephrectomy—A case report. Cancer Chemotherapy & Pharmacology, 95(1), 1-7.
Cita Chicago Style (17a ed.)
Hulskotte, Lotte M. G., Loek A. W. de Jong, Alwin D. R. Huitema, Joost Sijm, Ingrid Desar, Minke Smits, y Nielka P. van Erp. "Substitution of Ifosfamide for Cyclophosphamide in the TI-CE Regimen: Pharmacology and Dose Justification in a Patient with Refractory Metastatic Germ-cell Tumor Post-nephrectomy—A Case Report." Cancer Chemotherapy & Pharmacology 95, no. 1 (2025): 1-7.
Cita MLA (9a ed.)
Hulskotte, Lotte M. G., et al. "Substitution of Ifosfamide for Cyclophosphamide in the TI-CE Regimen: Pharmacology and Dose Justification in a Patient with Refractory Metastatic Germ-cell Tumor Post-nephrectomy—A Case Report." Cancer Chemotherapy & Pharmacology, vol. 95, no. 1, 2025, pp. 1-7.
Precaución: Estas citas no son 100% exactas.